
Ok, so enough with the acronyms.....
Wednesday, February 2, 2011
Coriell and OSU integrate GWAS into an EMR!
Posted by
Steven Murphy MD
at
6:04 PM
4
comments
Labels: cpmc, gene sherpa, OSU, OSUMC
Wednesday, November 10, 2010
Consumer Genetic Testing for heart attack risk? Worthless!

Here are the top ten reasons why in its current state, direct to consumer or otherwise, genomic testing for cardiovascular disease risk is dead in the water
1. Family History Risk paints a far better picture and IT IS FREE
2. Reynolds and Framingham risk paint a more accurate picture
3. An independent panel has reviewed 58 variants, 29 genes, and gave the thumbs down.
4. The highest increased risk from any of these tests is 30%, Fam Hx can be as high as 500%
5. Kif6 was just shot down as a useful marker.
6. Clinical Utility has not been evaluated in ANY of these tests.
7. Spit Parties don't lower cholesterol
8. The FDA is hunting down these type of crazy claims!
9 . Topol's heart attack gene didn't pan out, why would these?
10. A recent 23 gene panel failed to make the grade as well.
Let me be crystal clear.
I am glad that the number one reason for ordering a DTCG test was curiosity and not true medical concern in the "early adopters"
But I am concerned that may not be the case for the next wave. I am concerned they will take these genetic tea leaves and use them.
The problem, most of these tests are disproven or will be in the next couple of years.
Loose associations with small increased risks sounds a lot like fortune telling or phrenology. Or hell, even birth order....
Someday we will have good predictive models, 10-15 years from now. But NOT Now! Do you hear that VC country, SV, NYC, Hedgies?
10 year exit strategy. Not 2 not 8. So stop hyping this bull$h!t and go invest in Gold or Commodities or something for the love of god!
The Sherpa Says: Did you hear the one about the research geneticist? He keeps telling his wife how great their sex life WILL BE! Someday we will have this tool, let's try not to burn out and cynicize the public yet.....HT Francis Collins
Posted by
Steven Murphy MD
at
5:50 PM
7
comments
Labels: 23andme, egapp, gene sherpa, heart attack gene, navigenics
Friday, April 23, 2010
99 USD, DNA day and patient letters
Posted by
Steve Murphy MD
at
8:29 AM
0
comments
Labels: 23 and me, dna day, effient, gene sherpa, plavix, steven murphy MD
Monday, August 24, 2009
PHG Foundation and my point.

A long time ago I had a post entitled "Beware Doctors Bearing Genetic Tests" back in April of 2007. It was an interesting post where I point out that this wonderful GI doctor who was IVY league trained completely hashed genetic testing for HNPCC.
I went on to explain the shortcomings with Internists in interpreting APC testing for familial adenomatoid polyposis coli. 1 in 3 misinterpret tests.....Wait till you see the DTC interpretation!
Everyone who gets all in a huff when I say that these DTC genetic tests should be regulated. But I am here to say there is a good reason for it, and it has nothing to do with the people getting the tests.......There is now threat of public harm.....
But first let me explain my frustration. Saturday I was on Twitter and Daniel MacArthur and I had a conversation, which he lead off by saying:
"@helixhealthct Just shows how arbitrary most medical care is anyway; not like it'll change the outcomes much.2:46 AM Aug 22nd from TweetDeck in reply to helixhealthct"
Which was in response to a PHG report on an article published in Genetic In Medicine [Kolor K et al. (2009) Genet Med 11(8):595].
Among the 1880 physicians sampled, 42% were aware of the tests(DTC Genetic tests) and, over the past year, 15% had at least one patient bring the results of such a test to them for discussion. Interestingly, of this latter group, 75% (212 physicians) indicated that the results had changed some aspect of their patient’s care.
Holy Crap! Really? 75% changed the care?
So it had me begging several questions.
1. Did the physician read the Terms of Service for the DTC test? "Not to be used to make medical decisions"
2. Did the patient read the Terms of Service when they brought this test to the physician.
3. How is the physician supposed to know that this is not a clinically validated genetic test?
4. How is the busy clinician to differentiate this test from other clinically valid tests?
5. Why did the patient bring the test to the doctor? Was it due to DTC marketing efforts?
I was pissed at Daniel. How dare he say what we as physicians do changes no health outcomes!
In some instances he may be right. In others I wondered how complaints may actually be neglected based on this "genetic test"
Did these 212 doctors know something I don't about the utility of this DTC testing?
I doubt it.
I am seriously concerned that the 3/4ths of the 18% had actually changed care based on a non-clinical based test. That, to me is Scary AS HELL!!!!!
Think on this for a second.....How many of these doctors will ignore chest pain complaints based on a low genetic risk?
Now think on this. How many doctors will unnecessarily order stress tests for patients who have no complaints and are "High Risk"?????
Either way you slice it, 3/4 of these doctors are acting incorrectly, or at least not according to evidence base.
This survey proved one thing to me. Doctors have no F^CK!n& Clue what they are doing with genomics!
Why should these tests be regulated?
1. Patients aren't following the terms of service, likely due to deceptive advertising
2. Doctors can pose a threat based on inaccurately using these tests
3. Over use of resources could end up being a big problem because of these tests.
4. The potential for public harm has now gone from silly consumer, to trained medical professional inflicting damage.......
The Sherpa Says: Like I said, beware doctors bearing genetic tests........and patients too.
Posted by
Steve Murphy MD
at
4:49 AM
7
comments
Labels: 23andme, daniel macarthur, deCODEme, gene sherpa, gene tests, Helix Health of Connecticut, informed medical decisions, Muin Khoury, navigenics
Wednesday, August 19, 2009
Family History, State of the Science

The NIH/CDC is hosting a conference next week. I conference I wish I could go to, but alas, I will be DOING family histories on my patients that week.
The conference will be held at the NIH in Bethesda. This is an NIH state of the science conference about Family History and its usefulness.
I for one, am very glad that the government is trying to address this super important issue. It is beyond due for an evaluation.
Why?
With the cost of a genome going to drop to 5000 USD by the late fall (trust me), we will soon see another level of DTC and Clinical lab set offering the genome as a predictive tool.
There are several reasons that Family History beats a Genome (For Now)
1. Phenotypic data of family history represents complex interplay of genes and environment
There is no way that a simple genome will be able to give us the story of how a human will develop. That is predicted by environment and genes, which are successfully covered by..... A family history.
2. 5000 USD is still more than what it costs to obtain a family history.
By the time the software tools are released, we will see that social networking and the internet will transform the costs of family history next to nothing. Which is still a long way to go for the genome scans.
3. We have no clue what most of the genome data means.
Indels or CNVs or SNPs, we have no freaking clue what most mean, we do know what a heart attack at 40 means.......
4. Even if we had everyone's genome scans, we would still need phenotypic data and pedigrees.
What's the one thing we do when we have an intellectually delayed child with an abnormal CMA/CGH? We test the parents. Looking for THEIR phenotypes to make sense of the genome mess.
Look, people always give me reasons why the genome is important and a family history is useless.
I've heard them.
-"We don't speak with that side of the family"
-"My father lived with his uncle, because his father died (secretly running the empire as Darth Vader)"
-"I was adopted by Bail Organa, only to find out I have a lost twin brother"
There is one thing that will always be certain over time, there will be some screwed up family dynamics making it difficult (BUT NOT IMPOSSIBLE) to obtain an accurate family history.
That being said, it is still often useful to capture those who you can. And still less expensive.
I look forward to the briefings from this conference, and Muin, if you are listening, I would love to have the link to the webcasts.... Oh wait, they have that too! Sweet.
If you can't be there, you can get the information you seek!
Once again, we need a state of the science on genome prediction, not a consensus statement a real eval of the state of the science. When placed side by side with the state of the science for a family history, we will soon see why family history is the preferred screening tool and will likely to continue that way, perhaps in conjunction with a genome scan, but genomes will NEVER replace family history.
The Sherpa Says: The press better be at this conference and report on Family History. And to the founders of Geni.com, you missed on this one when Tindall presented to you. Or maybe you just are going to steal the idea.........
Posted by
Steve Murphy MD
at
4:50 AM
5
comments
Labels: ancestry.com, CDC, family history, francis collins, gene genie, gene sherpa, geni.com, Helix Health of Connecticut, Muin Khoury, NIH
Wednesday, March 4, 2009
Duh!!! For at least 5 years we "knew" this!! PPIs and 2C19
- Prescribed to prevent a second heart attack or stroke
- Prescribed to prevent a clot forming in a coronary artery stent, which one often receives after having a heart attack
- Given in patients with PAD
It turns out that in order for this medication to work it needs to be converted from Plavix into its active metabolite. This type of medication is called a Pro-Drug. There are others like this, including tamoxifen and codeine.
Well, the enzyme which converts Plavix to its active metabolite is called CYP 2C19. We have known this since 2000. A professor of mine actually published on this back then. We even knew about so called "Plavix resistance" .
We know theorize that Plavix resistance is mainly due to polymorphisms in CYP 2C19. This has been studied since 2000, but only recently came to major light with articles in Lancet, New England Journal of Medicine......and my rants on this Blog and in Lectures at Yale and Affiliated Hospitals....
Now........the fly in the ointment....
Proton Pump Inhibitors(PPIs) like Prilosec and Protonix........Are available over the counter since they are so "benign"......
Well, we have known and studied since 1997 that Prilosec inhibited 2C19's ability to biotransform other medications.
So what about allof the people taking BOTH Plavix and PPIs? Let me guess.... the results are like the data in 1997!!!!! That patients receiving both medications have little Plavix effect and decreased platelet inhibition.
Well, that was shown in 2006 and even some preliminary data in 2004.
So one has to ask, well why haven't we put anything on the label? Why haven't their been huge warnings....even more so....how many people are on Plavix and PPIs? The pharma companies know.......how come they haven't warned people pre-emptively that there "May be a problem"
The FDA always asks how much evidence is enough.....but now with the study just published in JAMA it is painfully clear.....we have missed the boat by requiring TOO MUCH PROOF!!
What does the study say? Those who are on Plavix and Prilosec are 27% more likely to have a recurrent hospitalization or DEATH from acute coronary syndromes than those NOT ON THIS COMBINATION!!!
AND, 2 of 3 people in this study on Plavix......were ALSO on Prilosec!!!!
This study was a retrospective study which does have limitations, but has me asking why do we have 3 years of data on this combo 2003-2006, when we knew that there may have been a problem back in 2000????
Why didn't we do a better post market analysis?
What's even worse......people advocating pharmacogenomics are getting push back from lazy clinicians who are asking for randomized double blinded studies to PROVE this problem.....
But here's what they don't know.....the pharmacology literature is robust with Pgx data, just as it was with PPI 2C19 inhibition data....Too bad doctors don't read pharmacology literature....
Anecdotally, when I was a resident, I pulled all of my patients off PPIs that were on Plavix. What did I do? I did a med reconciliation and became aware of the possible interaction.....In this case it was NO BIG DEAL to put them on H2 blockers instead......
Primum Non Nocere.......not PRIMUM RANDOM DOUBLE BLINDUM.....
This just pisses me off.........9 years to come to clinical light........That is a damn shame, That may also happen with Prasugrel....
The Sherpa Says: Why do we as physicians wait for a large organization to say stop, when we have the education to figure out from the literature when we should have stopped? Or for that matter, when we should have started......the burden of evidence has been overcome here.....Unlike SNP Scans.......
Posted by
Steve Murphy MD
at
7:48 AM
1 comments
Labels: 2c19, CYP450, gene sherpa, Helix Health of Connecticut, JAMA, Lancet, NEJM, pharmacogenomics, plavix, prilosec, protonix
Monday, December 22, 2008
Copy Number Variation, Epigenetics. Bio 400? No, NatGeo!
Posted by
Steve Murphy MD
at
4:02 AM
3
comments
Labels: 23andme, coriell personalized medicine collaborative, deCODEme, gene sherpa, Helix Health of Connecticut, navigenics, population diagnostics, total diagnostics
Saturday, December 15, 2007
Not Again OMG UK!
FH occurs in two forms. The more common version, heterozygous FH, affects 1 in 500 people. It is caused by a single mutated gene, which raises cholesterol and thus the risk of hardened arteries, heart disease and stroke. It can usually be managed with statin drugs and diet.
Britain’s first licence to test embryos for FH will be awarded next week to Paul Serhal, of University College Hospital in London, by the Human Fertilisation and Embryology Authority (HFEA).
Its decision breaks new ground because it permits Mr Serhal to screen out not only the severe form of the condition but also the milder type, which is usually treatable.
So where do we go from here? Gattaca.
Well, this certainly is a slippery slope. Let me know your opinion. This Times readers opinion says is very nicely
Martha Ware, Hammonton,NJ, NJ/USA
-Steve
Posted by
Steve Murphy MD
at
4:36 PM
12
comments
Labels: britain, drudge report, gene sherpa, Helix Health of Connecticut, lipitor, PGD, times online, UK
Sunday, November 11, 2007
Scienceroll reviews Personalized Medicine Companies
"If we could merge the real advantages of these companies:
- the fantastic team of Navigenics and their unique business model;
- the financial background of 23andMe; the focus on genealogy information and social networking;
- the personal aspect of Helix Health of Connecticut and their potential to serve and help physicians as well,
Posted by
Steve Murphy MD
at
7:54 AM
5
comments
Labels: 23 and me, Craig Venter genes, DNA direct, francis collins, gene sherpa, gene tests, Helix Health of Connecticut, Myriad, navigenics
Monday, October 1, 2007
What the F*&^

Posted by
Steve Murphy MD
at
4:09 PM
3
comments
Labels: 23 and me, 454, cambridge genomics, Craig Venter genes, DNA direct, Eye on DNA, gene sherpa
Thursday, September 27, 2007
Genetic Disease? Isn't she too Old for that?
Posted by
Steve Murphy MD
at
5:09 PM
2
comments
Labels: gene sherpa, gene tests, genetic discrimination, internal medicine, internist, tangier's disease
Monday, September 17, 2007
I want my Genome!! What about your cholesterol?
Posted by
Steve Murphy MD
at
6:00 PM
1 comments
Labels: cholesterol, gene genie, gene patents, gene sherpa, gene tests, kimball genetics, Myriad
Sunday, September 16, 2007
Readers' Corner
I just wanted to highlight a comment made by one of my readers. I think it illustrates the point of screw your safety, we're taking this Prime Time
From my comment section:
I don't disagree that there is and will be a "gap phase" but the assertion that "overselling genomics could ruin the promise of personalized medicine" is ludicrous! The technology is going wherever it can no matter what - the more "wild west" the approach, the more tracks get followed, then darwinism (and capitalism) takes over and the worst ideas die off anyway. Otherwise, why don't we still have people with red flags walking in front of our cars? Where is the grand thinking that took the US to the moon nearly 40 years ago? "Nanny-state" thinking and unnecessary caution is this country's worst enemy.
Nanny State?
I guess child labor laws are nanny state.
What about making sure children's toys don't have lead paint on them? Oh, but that would be nanny state too. Clearly interfering with the progress of corporate america...
The Sherpa Says: I hope this comment puts this square in your face. Let the buyer beware, because the seller isn't going to. I imagine they did a boatload of calculations and assurances of safety PRIOR to ever launching that rocket. You always should when human safety is on the line. But heck, why should we with genomics in medicine? That would just be a nanny state. The lack of regard for human safety and medical malpractice is disgusting........ To this esteemed reader. I agree to disagree.
Posted by
Steve Murphy MD
at
3:53 PM
3
comments
Labels: gene sherpa, gene tests, nanny state, the shmoopies
Sunday, August 26, 2007
Send in the Clowns......
The Gene Genie is at Microbiology Bytes this week. The theme is bugs and beyond. It has been 7 genies since my hosting and the topics just keep getting better. I am so impressed by the set of links posted, from evolutionary bacteriology to pharmacogenomics there is a lot in the bottle this go 'round.
I have been moving off topic lately and I promise to start redirecting. I have been guiding your attention towards the business side simply because there are so many shenanigans out there. I firmly believe that the revolution known as personalized medicine will be manipulated, just as the "organic food" wave was. Pretty soon you have everything from organic food to organic car washes.
Perhaps the next move is Procter and Gamble releasing Genomically Targeted Food, personalized just for you. Where will this start? Not in your foods, but in Fido's. I have recently discovered from several sources, including I guy (venutre capitalist) who I bumped into waiting to buy power ball tickets, that there are several food manufacturers working on nutrigenomic cat, dog, and parakeet food!!!
All that glitters isn't gold and all that buy it aren't fools. They can be tremendously smart people that are duped by marketing. I ask that we all take a step back, take inventory and prepare for the avalanche of marketing about to hit the air waves.....From Myriad and Sheryl Crow to Puppy Chow...please don't dismiss Personalized Medicine as more of the same charlatanism. We have something revolutionary, it is a shame if we let the PR, Marketing, and VC fools run us into the ground for a cheap buck or two!
The Sherpa Says: Thanks for reading.....please stick to the trail and we will get there safe and sound, I promise. Oh and BTW, I am still awaiting Salugen's studies and data.
Posted by
Steve Murphy MD
at
11:14 AM
0
comments
Labels: celera genomics, gene patents, gene sherpa, genetic testing, kimball genetics
Sunday, July 29, 2007
What good is a map?
- Can you read the map? I used to be in the Navy. We learned how to read nautical maps. But my father, a retired colonel in the Army, would have no clue where to begin. Imagine someone who had no training......
- Where are you on that map? If you have no orientation, how could you hope to navigate. Where does the sun rise? Simple question. However, when asked almost 15% of Americans do not know the answer.
- What is on the land you will be paddling to? If you paddle hard to get there only to find out that there are man eating natives, how good was your choice? Did you really want to find that land?
A map of your personal genome is much the same. Jason Bobe over at the Personal Genome comments on some of these topics. Who should be able to read the map? Should everyone have a Tom-Tom or Garmin? Should there be age limits on querying ability. And what if we find out something we didn't want to know? These are serious questions.
The Sherpa Says:
There will soon be a personal genome option. Everyone will be able to have an economically priced copy. We need some guidance on its interpretation. Personally, computers can only do so much. With all apologies to my colleauge Tim Arimond, we cannot program our way out of needing human interpretation. A computer cannot tell when you are scared, confused, upset......yet. I think that personal genome sequencing holds tremendous promise.........But it is only a map.
Posted by
Steve Murphy MD
at
8:59 AM
0
comments
Labels: cannibals, computational biology, computers, DNA direct, gene sherpa, gene tests, genetics, george church, personal genome project, pgp, raft
Tuesday, July 24, 2007
WikiPedia Meets Genetics
Posted by
Steve Murphy MD
at
4:03 PM
3
comments
Labels: abdominal aneurysm, CCR5, gene sherpa, gene tests, genetic discrimination, kentucky, OMIM, SNPedia, TCF7L2, wikipedia
Monday, July 2, 2007
Britain Needs A Sherpa!
Posted by
Steve Murphy MD
at
7:45 AM
5
comments
Labels: coumadin, direct to consumer, DNA direct, Eye on DNA, gene sherpa, gene tests, genetic counselor, london, UK
Tuesday, June 26, 2007
The Confusing Thing About Association Studies.
- Long Term Aspirin use prevents cancer incidence in colon 32%, prostate 19%, and breast cancer 17%* (statistically non-significant). There is some molecular evidence of this in colon cancer. But not the others....... The catch is that you have to use aspirin adult dose for >5 years. Why? Like most association studies.....No one knows. What good is that?
- Hormone replacement therapy increases Ovarian cancer incidence This study called the Million Women Study is a large cohort of British women. 948,576 postmenopausal women were assessed for ovarian cancer incidence. Users were 20% more likely to develop Ovarian Cancer. 1 in 5, that seems small, but in a million women (well......just 52k shy) that's alot of cancer!!! Especially such a nasty killer. But here's the kicker....
- Oral Contraceptive hormones Reduce Colorectal Cancer risk! Wait a second.....Aren't these female hormones too? This study shows an almost 40% reduced incidence of colon cancer in these women from the Women's Health Study. Perhaps this has to do with dosage? But Who Knows....It's an association study!!!
- Smoking Cuts Risk of Parkinson's Disease So that is what the media says about this study. Ok so now you have got me flipping out. No mechanism, No pathogenesis, No explanation.... Smoking kills, but at least it reduces your likelihood of ALSO having Parkinson's. Almost a 40% reduction in the likelihood of having Parkinson's. How? Who Cares....It's an association study! This kills me. The people could have predisposition genes for nicotine addiction/taste/etc which also have some salutatory effects. I do not think that smoking is what saves these patients brain cells!!!! But that's not what the press will tell you.
The Sherpa Says: What is sold as a good piece of science is quite often a piece of something else! Just because it was toiled over and hard work to develop it was done does not make it true, correct or even appropriate. I am here to say.....If it sounds fishy it probably smells fishy too. Throw out association studies until you have a reason for the association!!!
Posted by
Steve Murphy MD
at
3:58 PM
2
comments
Labels: brain cancer, Breast cancer, Colon cancer, gene sherpa, hormone therapy, parkinsons disease, quitting smoking, smoking, smoking cessation, The Gene Sherpa
Monday, June 25, 2007
2 months 3000 visitors!!!!!!
Thank you to everyone who picked up my slack on Sunday. I was unable to post the Medicine 2.0 Carnival because of an illness in the family :(
I would like to tell you how excited I am that I have reached 3000 sets of eyes. I am so invigorated by this whole process of blogging. I love educating the public and physicians and this blog is a labor of love. so thank you to all the readers out there.
Lastly I would like to draw attention to an amazing film director and radio talk show host Kathleen Slattery-Moschkau . She has just produced a new documentary to the medical community called PERx…it is available for viewing via the site www.perxinfo.org The film features internationally renowned experts from Harvard and other orgs. In a short time, continuing education credits will also be available to viewers and the film is also available to the general public. All for free (in order to watch the film, click on “educational modules”)
It is an amazing documentary. She has done others including Side Effects the movie with Grey's Anatomy start Katherine Heigl
Please take the time to watch this documentary as well as Side effects. You will be amazed at what you see.
Take Care
-The Sherpa
Posted by
Steve Murphy MD
at
12:40 PM
3
comments
Labels: gene sherpa, Katherine Heigl, Kathleen Slattery-Moschkau, personalized medicine, PERx, The Gene Sherpa
Monday, June 18, 2007
Forbes and Genetics Part 4
Ok,
Sorry I took off Sunday. I just want to take the time to make a public service announcement. Please talk with you loved ones about your wishes if you were to have a terminal illness. Sometimes these wishes can not be conveyed and this will lead to horrible outcomes. So please, please have a living will.
Thanks.
Now back to the slugfest!
I have received even more emails about these postings. Luckily none from Lawyers yet ;)
Round 4 BRCA1 and BRCA2:
From the article-One in 500 women have mutations in one of these genes, which normally keep tumors from growing. That gives them a 50% to 80% lifetime risk of breast cancer and a higher risk of ovarian cancer, too. The test costs $385 for women of Jewish ancestry who know they are at risk for a particular mutation. A broader test looking for any defect costs $3,120.
Succinct, accurate, and applicable. However, they did not get into BART testing as I had posted about in my Blame Portugal segment. The also did not point out that BRCA testing can detect pancreatic and prostate cancer risk as well. This could have been much more informative and useful............Sherpa 3 Forbes 2
Round 5 OncotypeDX:
From the article-This test looks at 21 different genes that can be out of whack in a breast cancer tumor and predicts how likely cancer is to come back after surgery. That helps women decide whether or not to get chemotherapy, which can cause side effects such as nausea, hair loss and numbness. The test costs $3,500 and is covered by MediCare, UnitedHealthcare and Aetna.
I am not so sure "out of whack" is the best way to describe this testing. Perhaps, "whose expression leads to poor outcomes and recurrence" is a better way to describe it. Well, I am one to mince words myself so I can't get too picky. But the answer is...Absolutely an important test. This has been proven, validated and replicated.
No doubt this round goes.....Sherpa 3 Forbes 3!
Round 6 TCF7L2 testing.
From the article-This variant, in a region called TCF7L2, doubles the risk of adult diabetes if you have two bad copies of it--10% of people do. It is the strongest diabetes-promoting gene yet discovered. DeCode Genetics sells a test for $500 via online test provider DNA Direct.
Ok, before I go slicing into this test several caveats. 1 I absolutely abhor testing for the sake of testing. Especially when the result is not definitive. It leads to confusion, poor compliance and a false sense of security. I am disgusted by this type of testing. Especially when just one sibling with diabetes gives you greater information.
Now to the dissection of this claim. First, this polymorphism is a good and replicated polymorphism. But not everyone with diabetes has this change. The gene is about risk and there is no study available which show there are significant steps you can do to mitigate this specific gene risk. True you can diet and exercise just like you would to prevent diabetes anyways. In addition, the increased risk given by just this one polymorphism is not that significant. What is more likely to change your life is a panel such including genes identified by Dr Collins et. al. This study was published before the Forbes article and they easily could have mentioned all of these genes in one part. But they did not. Why? I think it has to do with the ties to deCODE. But that's just the conspiracy theorist in me.
I have an issue with this quote-"It is the strongest diabetes-promoting gene yet discovered."
Wow!! In what population? There are other genes in populations not northern European that have higher risk. This statement is almost false!!! Frankly I think we should take a point away from Forbes for this. But I won't.
Sherpa 4 .... Forbes 3
The Sherpa Says: I love how the media mixes true things into their agenda. It is a sneaky way to appear factual and credible. If they would have to submit these things to peer review before publishing, then we would have a different story. How come no one holds journalists to scientist standards? Especially when writing about Science!!
Posted by
Steve Murphy MD
at
6:24 AM
0
comments
Labels: bart, BRCA, deCode, DNA direct, Eye on DNA, forbes, gene sherpa, gene tests, microarray, oncotype DX









